S. Jablonska, S. Majewski, S. Obalek, and G. Orth, Cutaneous warts, Clin Dermatol, vol.15, pp.309-319, 1997.
DOI : 10.1016/s0738-081x(96)00170-8

G. Orth, Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses, Semin Immunol, vol.18, pp.362-374, 2006.

N. Ramoz, L. A. Rueda, B. Bouadjar, L. S. Montoya, G. Orth et al., Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis, Nat Genet, vol.32, pp.579-581, 2002.
URL : https://hal.archives-ouvertes.fr/pasteur-00174726

A. W. Arnold, B. Burger, E. Kump, A. Rufle, S. K. Tyring et al., Homozygosity for the c.917A-4T (p.N306l) polymorphism in the EVER2/TMC8 gene of two sisters with epidermodysplasia verruciformis Lewandowsky-Lutz originally described by Wilhelm Lutz, Dermatology, vol.222, pp.81-86, 2011.

E. Hohenstein, P. L. Rady, M. Hergersberg, A. R. Huber, S. K. Tyring et al., Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A-4T polymorphism in the TMC8/EVER2 gene, Dermatology, vol.218, pp.114-118, 2009.

T. Patel, L. K. Morrison, P. Rady, and S. Tyring, Epidermodysplasia verruciformis and susceptibility to HPV, Dis Markers, vol.29, pp.199-206, 2010.
DOI : 10.1155/2010/345436
URL : http://downloads.hindawi.com/journals/dm/2010/345436.pdf

M. Lazarczyk, C. Pons, J. A. Mendoza, P. Cassonnet, Y. Jacob et al., Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses, J Exp Med, vol.205, pp.35-42, 2008.

A. I. Su, T. Wiltshire, S. Batalov, H. Lapp, K. A. Ching et al., A gene atlas of the mouse and human protein-encoding transcriptomes, Proc Natl Acad Sci, vol.101, pp.6062-6067, 2004.

S. Majewski, N. Hunzelmann, R. Nischt, B. Eckes, L. Rudnicka et al., TGF beta-1 and TNF alpha expression in the epidermis of patients with epidermodysplasia verruciformis, J Invest Dermatol, vol.97, pp.862-867, 1991.

J. R. Bradley, TNF-mediated inflammatory disease, J Pathol, vol.214, pp.149-160, 2008.

R. J. Moore, D. M. Owens, G. Stamp, C. Arnott, F. Burke et al., Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis, Nat Med, vol.5, pp.828-831, 1999.

H. Hsu, J. Xiong, and D. V. Goeddel, The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation, Cell, vol.81, pp.495-504, 1995.

M. Darding and P. Meier, IAPs: guardians of RIPK1, Cell Death Differ, vol.19, pp.58-66, 2012.

S. Tsutsumi, W. Tomisato, T. Hoshino, T. Tsuchiya, and T. Mizushima, Transforming growth factor-beta1 is responsible for maturation-dependent spontaneous apoptosis of cultured gastric pit cells, Exp Biol Med (Maywood), vol.227, pp.402-411, 2002.

F. Gonzalvez and A. Ashkenazi, New insights into apoptosis signaling by Apo2L/TRAIL, Oncogene, vol.29, pp.4752-4765, 2010.

S. Nagata, Apoptosis by death factor, Cell, vol.88, pp.355-365, 1997.

D. J. Schnepple, B. Shepard, G. D. Bren, N. W. Cummins, S. Natesampillai et al., Isolation of a TRAIL antagonist from the serum of HIV-infected patients, J Biol Chem, vol.286, pp.35742-35754, 2011.

R. Imamura, K. Konaka, N. Matsumoto, M. Hasegawa, M. Fukui et al., Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha, J Biol Chem, vol.279, pp.46415-46423, 2004.

Y. J. Lai, V. T. Lin, Y. Zheng, E. N. Benveniste, and F. T. Lin, The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration, Mol Cell Biol, vol.30, pp.5582-5596, 2010.

M. A. Ermolaeva, M. C. Michallet, N. Papadopoulou, O. Utermohlen, K. Kranidioti et al., Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses, Nat Immunol, vol.9, pp.1037-1046, 2008.

J. Y. Kim, J. Y. Lee, D. G. Kim, G. B. Koo, J. W. Yu et al., TRADD is critical for resistance to TRAIL-induced cell death through NF-kappaB activation, FEBS Lett, vol.585, pp.2144-2150, 2011.

X. Cao, Y. L. Pobezinskaya, M. J. Morgan, and Z. G. Liu, The role of TRADD in TRAIL-induced apoptosis and signaling, FASEB J, vol.25, pp.1353-1358, 2011.

L. Neumann, C. Pforr, J. Beaudouin, A. Pappa, N. Fricker et al., Dynamics within the CD95 death-inducing signaling complex decide life and death of cells, Mol Syst Biol, vol.6, p.352, 2010.

P. H. Krammer, R. Arnold, and I. N. Lavrik, Life and death in peripheral T cells, Nat Rev Immunol, vol.7, pp.532-542, 2007.

P. Cassonnet, C. Rolloy, G. Neveu, P. O. Vidalain, T. Chantier et al., Benchmarking a luciferase complementation assay for detecting protein complexes, Nat Methods, vol.8, pp.990-992, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-01971619

K. Kurima, Y. Yang, K. Sorber, and A. J. Griffith, Characterization of the transmembrane channellike (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis, Genomics, vol.82, pp.300-308, 2003.

J. Yuan and G. Kroemer, Alternative cell death mechanisms in development and beyond, Genes Dev, vol.24, pp.2592-2602, 2010.

L. Galluzzi and G. Kroemer, Necroptosis turns TNF lethal, Immunity, vol.35, pp.849-851, 2011.

C. Scaffidi, S. Fulda, A. Srinivasan, C. Friesen, F. Li et al., APO-1/Fas) signaling pathways, EMBO J, vol.95, pp.1675-1687, 1998.

X. Luo, I. Budihardjo, H. Zou, C. Slaughter, and X. Wang, Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors, Cell, vol.94, pp.481-490, 1998.

F. Van-herreweghe, N. Festjens, W. Declercq, and P. Vandenabeele, Tumor necrosis factormediated cell death: to break or to burst, that's the question, Cell Mol Life Sci, vol.67, pp.1567-1579, 2010.

J. Silke and R. Brink, Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs, Cell Death Differ, vol.17, pp.35-45, 2010.

L. Wang, F. Du, and X. Wang, TNF-alpha induces two distinct caspase-8 activation pathways, Cell, vol.133, pp.693-703, 2008.

S. L. Petersen, L. Wang, A. Yalcin-chin, L. Li, M. Peyton et al., Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis, Cancer Cell, vol.12, pp.445-456, 2007.

J. E. Vince, D. Pantaki, R. Feltham, P. D. Mace, S. M. Cordier et al., TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-(kappa)b and to prevent tnf-induced apoptosis, J Biol Chem, vol.284, pp.35906-35915, 2009.

P. K. Magnusson, P. Lichtenstein, and U. B. Gyllensten, Heritability of cervical tumours, Int J Cancer, vol.88, pp.698-701, 2000.

M. Scott, M. Nakagawa, and A. B. Moscicki, Cell-mediated immune response to human papillomavirus infection, Clin Diagn Lab Immunol, vol.8, pp.209-220, 2001.